Key Points

Commerce Minister Piyush Goyal reviewed the PLI scheme’s progress, stressing export competitiveness in key sectors. The scheme has attracted Rs 1.76 lakh crore in investments and created over 12 lakh jobs. Pharma and bulk drugs sectors have shown significant export growth under PLI. Goyal called for infrastructure improvements and skilled manpower to sustain this momentum.

Key Points: Piyush Goyal Pushes PLI Scheme for Export Growth in Key Sectors

  • Goyal urges ministries to resolve infrastructure bottlenecks
  • PLI scheme generated Rs 16.5 lakh crore in sales
  • Pharma sector saw Rs 1.7 lakh crore exports
  • Bulk drugs transitioned from net importer to exporter
3 min read

PLI scheme: Piyush Goyal calls for export competitiveness in key sectors

Commerce Minister Piyush Goyal emphasizes export competitiveness and self-reliance under PLI scheme, citing Rs 1.76 lakh crore investments and job creation.

"India must focus on sectors with competitive edge to boost exports – Piyush Goyal"

New Delhi, June 25

India must focus on the sectors in which it has competitive edge over other countries, and address the problems faced by the various stakeholders so that country’s exports can grow further, Commerce Minister Piyush Goyal said on Wednesday.

Chairing a review meeting on production-linked incentive (PLI) scheme in various sectors, Goyal urged the need for becoming self-reliant in the key sectors covered under the PLI scheme.

Emphasising that ministries should focus on creating quality skilled manpower instead of focusing on the quantity and resolve infrastructure bottlenecks in collaboration with NICDC (National Industrial Corridor Development Programme), Goyal stressed on preparing a roadmap for the next five years, both on investment and disbursement.

The PLI scheme is under various stages of implementation in 14 key sectors. The scheme has witnessed investments worth Rs 1.76 lakh crore, which has generated production/sales of over Rs. 16.5 lakh crore and employment of over 12 lakhs (direct and indirect) till March 2025.

According to the government, cumulative incentive amount of Rs 21,534 crore has been disbursed under PLI schemes for 12 sectors -- Large-Scale Electronics Manufacturing (LSEM), IT Hardware, Bulk Drugs, Medical Devices, Pharmaceuticals, Telecom & Networking Products, Food Processing, White Goods, Automobiles & Auto components, Specialty Steel, Textiles and Drones & Drone Components.

The impact of PLI schemes has been significant across various sectors in India. These schemes have incentivized domestic manufacturing, leading to increased production, job creation and a boost in exports.

For example, pharmaceutical drugs sector has witnessed cumulative sales of Rs 2.66 lakh crore which includes exports of Rs. 1.70 lakh crore achieved in the first three years of the scheme.

Export sales of eligible products under the scheme for FY 2024-25 was Rs 0.67 lakh crore, which is approximately 27 per cent of total pharma exports of the country during the same period, as per the Commerce Ministry data.

About 40 per cent of total investment (Rs 37,306 crore) amounting to Rs 15,102 crore has been undertaken by the approved companies under Research & Development (R&D) for eligible products under the scheme.

The PLI Scheme for Bulk Drugs has contributed to India becoming a net exporter of bulk drugs (Rs 2,280 crore) from net importer (Rs 1,930 crore) as was the case in FY 2021-22.

The Food Products scheme has reported investments worth Rs. 9,032 crore which has resulted in production/sales of Rs. 3,80,350 crore and employment of 3,40,116 (direct and indirect).

Moreover, exports of Indian Man-made Fibre (MMF) textiles have reached $6 billion during FY 2024-25 as against exports of $5.7 billion during the FY 2023-24.

The overall exports of Technical Textiles from India reached $3,356.5 million during FY 2024-25 as against exports of $2,986.6 million during FY 2023-24.

- IANS

Share this article:

Reader Comments

R
Rahul K.
Great initiative by the government! The PLI scheme is exactly what India needed to boost manufacturing. The numbers speak for themselves - Rs 16.5 lakh crore in production and 12 lakh jobs created is no small feat. Hope we continue this momentum and become truly self-reliant. 🇮🇳
P
Priya M.
While the PLI scheme has shown good results, I worry about the implementation at ground level. Many small manufacturers still face bureaucratic hurdles. The government should simplify processes and ensure benefits reach all eligible businesses, not just big players.
A
Amit S.
The pharma sector numbers are impressive! ₹1.70 lakh crore exports in 3 years shows we can compete globally. But we must ensure quality isn't compromised in the race for quantity. India's reputation as 'pharmacy of the world' is at stake.
N
Neha T.
Happy to see textiles doing well too! � But we need more focus on sustainable manufacturing. Can the PLI scheme include incentives for eco-friendly production methods? This will help us compete better in international markets where sustainability matters.
S
Sanjay P.
The shift from net importer to net exporter in bulk drugs is remarkable. This is strategic independence we needed. Now we must protect these industries from dumping by China and other countries trying to undercut our prices.
K
Kavita R.
Good progress, but what about job quality? 12 lakh jobs created is great, but are these well-paying, stable jobs? We need data on wages and working conditions too. Growth should benefit workers, not just companies.
V
Vikram D.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50